A transcatheter artificial valve

By adopting a radially retractable bracket, skirt frame and waist drum frame in transcatheter interventional artificial valve, balloon rupture and reflux problems are solved, and the installation accuracy and service life of the valve are improved.

CN110711052BActive Publication Date: 2024-12-03SHANGHAI NEWMED MEDICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201911101500.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2019-11-12
Publication Date
2024-12-03
Estimated Expiration
2039-11-12

AI Technical Summary

Technical Problem

The existing transcatheter interventional artificial valves have a risk of balloon rupture during valve pressing and opening, and the stent cannot be withdrawn after inaccurate release or failure for secondary release, which is not effective for valve stenosis caused by calcification. The efficacy of reflux problems is not obvious.

Method used

Using a radially retractable and self-expanding bracket, a skirt and a waist drum stand are set on the outside. The bracket is made of nickel-titanium memory alloy, the tissue valve leaves are sewn with the sealing film, the outer skirt is sewn on the skirt and drum stand, and the waist drum stand is used. immobilized on calcified native leaves.

Benefits of technology

It effectively avoids the risk of balloon rupture, reduces perival leakage of the valve, prevents reflux problems, and improves the safety, reliability and service life of the valve.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN110711052B_ABST
    Figure CN110711052B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of medical devices, and discloses a transcatheter interventional artificial valve. The artificial valve comprises a stent, a sealing membrane, a tissue leaflet, a skirt frame and an outer skirt, wherein the stent is an annular structure that can expand and contract radially; the sealing membrane is arranged on the inner surface of the stent; the tissue leaflet is arranged inside the stent, and the outer edge of the tissue leaflet is sutured to the inner surface of the sealing membrane; the skirt frame is protrudingly arranged on the outer side of the stent; the outer skirt is arranged on the outer surface of the stent, the upper end of the outer skirt is sutured to the stent, and the lower end of the outer skirt is sutured to the skirt frame, and the outer skirt can be unfolded with the skirt frame during the valve release process. The present invention can effectively reduce paravalvular leakage of the valve and prevent the problem of reflux.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical devices, and in particular to a transcatheter interventional artificial valve. Background Art

[0002] The heart has four valves. The valve between the left atrium and the left ventricle is the mitral valve, the valve between the right atrium and the right ventricle is the tricuspid valve, the valve between the aorta and the left ventricle is the aortic valve, and the valve between the pulmonary artery and the right ventricle is the pulmonary valve. Normal valves can maintain unidirectional blood flow by opening and closing according to the pressure difference on each side, ensuring that the blood in the chamber is pumped out without backflow. Many diseases, such as rheumatic heart disease and endocarditis, cause valvular lesions that impair the function of the valve. Among them, stenosis and regurgitation are common valvular diseases. Stenosis is caused by the inability of the valve to open completely, resulting in obstruction of blood flow. Thickening caused by calcification of the valve leaflets is a common cause of stenosis. Regurgitation is caused by the inability of the valve leaflets to close completely, resulting in blood backflow into the pumping chamber. Valve ring dilation, valve leaflet prolapse, and obstruction of valve leaflet activity are the main causes of regurgitation.

[0003] A transcatheter interventional artificial valve has been developed in the prior art, which introduces and implants an artificial heart valve by using a flexible catheter. In this technology, the artificial valve is installed by curling at the distal end of the flexible catheter. The catheter is introduced into the patient's blood vessel (such as the femoral artery or the carotid artery) and advanced through the blood vessel until the curled valve reaches the implantation site. By inflating the balloon installed on the valve, the valve is expanded to its functional size at the location of the defective native valve.

[0004] However, the existing balloon-expandable valve has the risk of balloon rupture during the process of valve compression and expansion, thus affecting the performance of the valve. Moreover, the balloon-expandable stent is made of cobalt-chromium alloy, and the stent does not have memory rebound performance when it is expanded and released at the valve ring. Once the stent is released inaccurately or fails, it cannot be withdrawn for a second release, and the only way to compensate is to consider valve-in-valve. In addition, the existing aortic valve is mainly used to treat valve stenosis caused by calcification, and the effect on reflux caused by paravalvular leakage is not obvious enough. Summary of the invention

[0005] Based on the above, the purpose of the present invention is to provide a transcatheter interventional artificial valve that can effectively reduce paravalvular leakage and prevent reflux problems.

[0006] To achieve the above object, the present invention adopts the following technical solutions:

[0007] A transcatheter interventional artificial valve comprises a stent, a sealing membrane, a tissue leaflet, a skirt frame and an outer skirt, wherein the stent is an annular structure capable of radial expansion and contraction; the sealing membrane is arranged on the inner surface of the stent; the tissue leaflet is arranged inside the stent, and the outer edge of the tissue leaflet is sutured to the inner surface of the sealing membrane; the skirt frame is protrudingly arranged on the outer side of the stent; the outer skirt is arranged on the outer surface of the stent, the upper end of the outer skirt is sutured to the stent, and the lower end of the outer skirt is sutured to the skirt frame, and the outer skirt can be unfolded along with the skirt frame during the valve release process.

[0008] As a preferred solution for a transcatheter interventional artificial valve, the stent includes a first grid group, a second grid group and a third grid group arranged from top to bottom, wherein the grid size in the first grid group is the largest, and the sealing membrane is sutured to the inner sides of the second grid group and the third grid group.

[0009] As a preferred solution for a transcatheter interventional artificial valve, three fixing ears are evenly arranged on the top of the stent along the circumference, and the fixing ears are used to fix the valve to a delivery device when the valve is implanted.

[0010] As a preferred solution for a transcatheter interventional artificial valve, three clamping ears are evenly arranged on the first grid group along the circumferential direction, and the clamping ears are used to fix the tissue leaflets.

[0011] As a preferred solution for a transcatheter interventional artificial valve, the stent is made by cutting nickel-titanium shape memory alloy.

[0012] As a preferred solution for a transcatheter interventional artificial valve, the skirt frame is inclined outwardly by 10° to 50° from the outer surface of the stent.

[0013] As a preferred solution for a transcatheter interventional artificial valve, the skirt frame is fixedly connected to the bracket by heat setting.

[0014] As a preferred solution for a transcatheter interventional artificial valve, the skirt frame is U-shaped, including vertical bars on both sides and a horizontal bar at the bottom, and the upper ends of the vertical bars are connected to the upper parts of the grid units in the third grid group.

[0015] As a preferred solution for a transcatheter interventional artificial valve, the skirt frame is formed by folding downward the upper parts of sequentially spaced grid units in the third grid group.

[0016] As a preferred solution for a transcatheter interventional artificial valve, a waist drum frame is further provided on the bracket, and the waist drum frame is inclined outwardly by 5° to 40° from the outer surface of the bracket.

[0017] The beneficial effects of the present invention are:

[0018] The present invention uses a radially contractible and self-expandable stent to facilitate more accurate installation of the valve at the target position, and compared with the balloon valve in the prior art, it can avoid the risk of balloon rupture during expansion; by arranging a skirt frame protruding from the outside of the stent and sewing the outer skirt to the skirt frame, the outer skirt can be fully expanded with the skirt frame during valve release, effectively reducing paravalvular leakage of the valve and preventing reflux problems; by providing a waist drum frame, the artificial valve can be conveniently and firmly fixed on the calcified native leaflet, thereby improving the safety, reliability and service life of the valve. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 is a structural diagram of a transcatheter interventional artificial valve provided in Example 1 of the present invention;

[0020] Figure 2 It is a structural diagram of a stent and a skirt frame in a transcatheter interventional artificial valve provided in Example 1 of the present invention;

[0021] Figure 3 Schematic diagram of a transcatheter interventional artificial valve implanted in the left ventricular outflow tract provided by Embodiment 1 of the present invention;

[0022] Figure 4 It is a structural diagram of a stent and a skirt frame in a transcatheter interventional artificial valve provided in the second embodiment of the present invention;

[0023] Figure 5 is a structural diagram of a transcatheter interventional artificial valve provided in Embodiment 3 of the present invention;

[0024] Figure 6 It is a structural diagram of a stent, a skirt frame and a waist drum frame in a transcatheter interventional artificial valve provided in Example 3 of the present invention;

[0025] Figure 7 It is a top view of the transcatheter interventional artificial valve provided in Example 3 of the present invention.

[0026] In the figure:

[0027] 1-Stent; 11-First grid group; 12-Second grid group; 13-Third grid group; 2-Sealing membrane; 3-Tissue leaflet; 4-Pan skirt frame; 41-Vertical rod; 42-Horizontal rod; 5-Outer pan skirt; 6-Fixing ear; 7-Clip ear; 8-Waist drum frame; 100-Left ventricular outflow tract. DETAILED DESCRIPTION

[0028] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It is to be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention. It should also be noted that, for ease of description, only the parts related to the present invention, rather than all structures, are shown in the accompanying drawings.

[0029] In the description of the present invention, unless otherwise clearly specified and limited, the terms "connected", "connected", and "fixed" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0030] In the present invention, unless otherwise clearly specified and limited, a first feature being "above" or "below" a second feature may include that the first and second features are in direct contact, or may include that the first and second features are not in direct contact but are in contact through another feature between them. Moreover, a first feature being "above", "above" and "above" a second feature includes that the first feature is directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below", "below" and "below" a second feature includes that the first feature is directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.

[0031] In the description of this embodiment, the terms "upper", "lower", "left", "right", etc., and the orientation or position relationship are based on the orientation or position relationship shown in the drawings, and are only for the convenience of description and simplification of operation, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operate in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first" and "second" are only used to distinguish in the description and have no special meaning.

[0032] Embodiment 1

[0033] Figure 1 is a structural diagram of a transcatheter interventional artificial valve provided in this embodiment; Figure 2 It is a structural diagram of a stent and a skirt frame in a transcatheter interventional artificial valve provided in this embodiment; Figure 3 It is a schematic diagram of the transcatheter interventional artificial valve provided in this embodiment being implanted in the left ventricular outflow tract.

[0034] like Figure 1-Figure 3As shown, this embodiment provides a transcatheter interventional artificial valve, including a stent 1, a sealing membrane 2, tissue leaflets 3, a skirt frame 4 and an outer skirt 5, wherein the stent 1 is an annular structure that can shrink and expand radially; the sealing membrane 2 is arranged on the inner surface of the stent 1, and the sealing membrane 2 is sutured to the stent 1; the tissue leaflets 3 are arranged inside the stent 1, and the tissue leaflets 3 are fixed to the stent 1 through clip ears 7, and the outer edges of the tissue leaflets 3 are sutured to the inner surface of the sealing membrane 2; the skirt frame 4 is protrudingly arranged on the outside of the stent 1; the outer skirt 5 is arranged on the outer surface of the stent 1, the upper end of the outer skirt 5 is sutured to the stent 1, and the lower end of the outer skirt 5 is sutured to the skirt frame 4, and the outer skirt 5 can be unfolded with the skirt frame 4 during the valve release process.

[0035] This embodiment uses a radially shrinkable and self-expandable stent 1 to facilitate more accurate installation of the valve at the target position, and can avoid the risk of balloon rupture during expansion compared to the balloon valve in the prior art; by protruding a skirt frame 4 on the outside of the stent 1 and sewing the outer skirt 5 to the skirt frame 4, the outer skirt 5 can be fully expanded along with the skirt frame 4 during the valve release process, effectively reducing paravalvular leakage of the valve and preventing reflux problems.

[0036] Specifically, if Figure 2 As shown, the stent 1 of this embodiment includes a first grid group 11, a second grid group 12 and a third grid group 13 arranged from top to bottom, each grid group includes a plurality of hexagonal grids arranged in rows, and each hexagonal grid includes two upper oblique rods, two middle straight rods and two lower oblique rods. This embodiment adopts three groups of vertically arranged hexagonal grid structures, so that the stent 1 can obtain a smaller clamping diameter when being clamped, and can have a greater radial support force when released. Figure 3 As shown, this embodiment is preferably an aortic valve, which is applied to the valve ring of the left ventricular outflow tract 100, such as Figure 3 In the figure, the end where the first grid group 11 is located is the outflow end, and the end where the third grid group 13 is located is the inflow end. Among the three grid groups, the hexagonal grids in the first grid group 11 are the largest in size and belong to a large grid structure. This setting can enable the valve to obtain larger meshes at the outflow end, reducing the risk of coronary artery blockage; while the hexagonal grids in the second grid group 12 and the third grid group 13 belong to a small grid structure, which is more rigid than the large grid structure and can provide better radial support when the valve is released to the valve ring position.

[0037] Furthermore, three fixing ears 6 are evenly arranged along the circumference at the top of the stent 1, and the three fixing ears 6 are arranged symmetrically in the center. The fixing ears 6 are used to fix with the delivery device when the valve is implanted, and the valve is delivered to the valve ring by the delivery device, and the valve is released and expanded to replace the diseased native valve. Furthermore, three clamping ears 7 are evenly arranged along the circumference on the first grid group 11, and each clamping ear 7 is located at the connection of two adjacent hexagonal grids. The clamping ears 7 are used to firmly fix the tissue leaflets 3, so that the valve can obtain good fluid dynamics performance during the opening and closing of the tissue leaflets 3.

[0038] Preferably, the stent 1 of the present embodiment is cut from nickel-titanium memory alloy. Compared with the balloon-expandable valve, the present embodiment adopts a nickel-titanium alloy stent 1. The stent 1 is compressed and loaded into a conveyor. When the stent 1 reaches the valve ring through the conveyor, it begins to be released. By utilizing the self-expansion property of nickel-titanium memory alloy, the stent 1 can rebound to its shape before compression, thereby avoiding the risk of balloon rupture during the process of expanding the stent 1 with a balloon. Moreover, in the case where the release of the valve position is not ideal, the stent 1 can also be released a second time.

[0039] The tissue leaflets 3 of this embodiment are composed of three symmetrical leaflets, which can be formed of pericardial tissue (e.g., bovine pericardial tissue), biocompatible synthetic materials, or various other suitable natural or synthetic materials. Each leaflet has a rectangular shape at one end and a fan-shaped portion at the other end, which is fixed by suturing to the inner side of the sealing membrane 2. The structure of the tissue leaflets 3 can refer to the arrangement in the prior art, which is not the focus of the present invention and will not be described in detail in this embodiment.

[0040] In the stent 1, the sealing membrane 2 is sutured to the inner side of the second mesh group 12 and the third mesh group 13 by sutures. The main function of the sealing membrane 2 is to fix the tissue leaflets 3 to the stent 1 and to form a good seal between the valve and the natural ring to reduce valve regurgitation. The sealing membrane 2 is preferably made of a tough, tear-resistant material, such as polyethylene terephthalate (PET). The outer skirt 5 is fixed to the outer surface of the stent 1. When the stent 1 is in an expanded state, there is excess material and slack between the upper and lower edges of the outer skirt 5, rather than being close to the outer surface of the stent 1. This arrangement allows the excess material of the outer skirt 5 to fill the gap between the stent 1 and the surrounding natural ring when the valve is implanted at the valve ring, which helps to form a good fluid seal between the valve and the natural ring.

[0041] In this embodiment, after the stent 1 is cut out, the skirt frame 4 is fixedly connected to the stent 1 by heat setting, and the skirt frame 4 is also preferably made of nickel-titanium memory alloy. Further preferably, the angle at which the skirt frame 4 is inclined outward from the outer surface of the stent 1 is 10° to 50°, preferably 25° to 35°. This setting can greatly expand the deployment range of the outer skirt 5 and ensure that the skirt frame 4 has a good support effect. Specifically, the skirt frame 4 of this embodiment is U-shaped, including vertical rods 41 on both sides and a horizontal rod 42 at the bottom. The upper end of the vertical rod 41 is connected to the upper oblique rod of the hexagonal grid in the third grid group 13. This setting can greatly increase the coverage of the outer skirt 5 and ensure that the stent 1 and the skirt frame 4 have good support strength. In this embodiment, by setting the skirt frame 4, the outer skirt 5 can be fully deployed with the skirt frame 4 during the valve release process; if there is no skirt frame 4, the outer skirt 5 formed only by folds is more difficult to deploy than the outer skirt 5 on the skirt frame 4. Therefore, by providing the skirt frame 4, the present embodiment increases the size of the outer skirt 5, and can reduce the regurgitation existing in the valve to a greater extent.

[0042] Embodiment 2

[0043] This embodiment discloses a transcatheter interventional artificial valve, which is basically the same in structure as that in the first embodiment, except that the arrangement of the skirt frame 4 is different.

[0044] Figure 4 1 is a structural diagram of the stent and skirt frame in the transcatheter interventional artificial valve provided in this embodiment. Figure 4 As shown, the skirt rack 4 is formed by folding down the top of the hexagonal grids spaced in sequence in the third grid group 13, that is, the two upper oblique rods of the hexagonal grids are folded down to form the skirt rack 4. Similar to the first embodiment, the skirt rack 4 is also processed by heat setting after the bracket 1 is cut out; after folding, the angle between the skirt rack 4 and the outer surface of the bracket 1 is 10° to 50°, preferably 25° to 35°. This embodiment uses spaced hexagonal grids folded down to form the skirt rack 4, which can achieve the same effect as the first embodiment, and has a simpler structure than the first embodiment, is more convenient to process, and saves materials and costs.

[0045] In this embodiment, the support 1 is folded to form a skirt frame 4, and then the outer skirt 5 is sewn to the skirt frame 4, so that the outer skirt 5 can be fully expanded along with the skirt frame 4 during the valve release process, effectively reducing the paravalvular leakage of the valve and preventing the reflux problem.

[0046] Embodiment 3

[0047] This embodiment discloses a transcatheter interventional artificial valve, which is basically the same in structure as that in the second embodiment, except that a waist drum frame 8 is added in this embodiment.

[0048] Figure 5 is a structural diagram of a transcatheter interventional artificial valve provided in this embodiment; Figure 6 It is a structural diagram of the stent, skirt frame and waist drum frame in the transcatheter interventional artificial valve provided in this embodiment; Figure 7 FIG. 2 is a top view of the transcatheter interventional artificial valve provided in this embodiment. Figure 5-Figure 7 As shown, the bracket 1 of this embodiment is also provided with a waist drum frame 8 for fixing the artificial valve on the calcified native valve leaflet. Preferably, the waist drum frame 8 is V-shaped, and its two upper ends are respectively connected to the upper oblique rods of the hexagonal grid in the second grid group 12, and the bottom end is tilted outward from the outer surface of the bracket 1. Specifically, the waist drum frame 8 is tilted outward from the outer surface of the bracket 1 at an angle of 5° to 40°, so as to achieve a better fixing effect.

[0049] This embodiment uses a radially contractible and self-expandable stent 1 to facilitate more accurate installation of the valve at the target position, and can avoid the risk of balloon rupture during expansion compared to the balloon valve in the prior art; by arranging a skirt frame 4 protruding from the outside of the stent 1 and sewing the outer skirt 5 to the skirt frame 4, the outer skirt 5 can be fully expanded along with the skirt frame 4 during the valve release process, effectively reducing paravalvular leakage of the valve and preventing reflux problems; by providing a waist drum frame 8, the artificial valve can be conveniently and firmly fixed on the calcified native leaflet, thereby improving the safety, reliability and service life of the valve.

[0050] Note that the above are only preferred embodiments of the present invention and the technical principles used. Those skilled in the art will understand that the present invention is not limited to the specific embodiments described herein, and that various obvious changes, readjustments and substitutions can be made by those skilled in the art without departing from the scope of protection of the present invention. Therefore, although the present invention has been described in more detail through the above embodiments, the present invention is not limited to the above embodiments, and may include more other equivalent embodiments without departing from the concept of the present invention, and the scope of the present invention is determined by the scope of the appended claims.

Claims

1. A transcatheter interventional artificial valve, characterized in that: include: A stent (1), wherein the stent (1) is an annular structure capable of radial contraction and self-expansion; A sealing film (2) is provided on the inner surface of the support (1); A tissue leaflet (3) is arranged inside the support (1), the tissue leaflet (3) is fixed to the support (1) via a clip ear (7), and the outer edge of the tissue leaflet (3) is sutured to the inner surface of the sealing membrane (2); A skirt rack (4), the skirt rack (4) being protrudingly arranged on the outside of the bracket (1); An outer skirt pocket (5) is arranged on the outer surface of the support (1), the upper end of the outer skirt pocket (5) is sewn to the support (1), the lower end of the outer skirt pocket (5) is sewn to the skirt pocket frame (4), and the outer skirt pocket (5) can be unfolded along with the skirt pocket frame (4) during the valve release process; The support (1) comprises a first grid group (11), a second grid group (12) and a third grid group (13) arranged in sequence from top to bottom, wherein the grids in the first grid group (11) have the largest size, and the sealing film (2) is sutured to the inner sides of the second grid group (12) and the third grid group (13); The skirt rack (4) is formed by folding downward the upper parts of sequentially spaced grid units in the third grid group (13).

2. The transcatheter interventional artificial valve according to claim 1, characterized in that: The top end of the stent (1) is evenly provided with three fixing ears (6) along the circumferential direction, and the fixing ears (6) are used to fix to a conveying device when the valve is implanted.

3. The transcatheter artificial valve according to claim 1, characterized in that: Three clamping ears (7) are evenly arranged on the first grid group (11) along the circumferential direction.

4. The transcatheter interventional artificial valve according to any one of claims 1 to 3, characterized in that: The stent (1) is made by cutting nickel-titanium memory alloy.

5. The transcatheter artificial valve according to claim 1, characterized in that: The skirt rack (4) is inclined outwardly at an angle of 10° to 50° from the outer surface of the bracket (1).

6. The transcatheter artificial valve according to claim 1, characterized in that: The skirt rack (4) is fixedly connected to the bracket (1) by heat setting.

7. The transcatheter artificial valve according to claim 1, characterized in that: The support (1) is also provided with a waist drum frame (8), and the waist drum frame (8) is inclined outwardly at an angle of 5° to 40° from the outer surface of the support (1).